Bionexus Gene Lab Stock Technical Analysis
| BGLC Stock | USD 3.94 0.04 1.03% |
As of the 10th of January, BioNexus Gene shows the Standard Deviation of 3.0, mean deviation of 2.32, and Risk Adjusted Performance of (0.09). BioNexus Gene Lab technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
BioNexus Gene Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as BioNexus, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to BioNexusBioNexus Gene's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.BioNexus Gene technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
BioNexus Gene Lab Technical Analysis
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of BioNexus Gene Lab volatility. High ATR values indicate high volatility, and low values indicate low volatility.
BioNexus Gene Lab Trend Analysis
Use this graph to draw trend lines for BioNexus Gene Lab. You can use it to identify possible trend reversals for BioNexus Gene as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual BioNexus Gene price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.BioNexus Gene Best Fit Change Line
The following chart estimates an ordinary least squares regression model for BioNexus Gene Lab applied against its price change over selected period. The best fit line has a slop of 0.03 , which may suggest that BioNexus Gene Lab market price will keep on failing further. It has 122 observation points and a regression sum of squares at 26.44, which is the sum of squared deviations for the predicted BioNexus Gene price change compared to its average price change.About BioNexus Gene Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of BioNexus Gene Lab on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of BioNexus Gene Lab based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on BioNexus Gene Lab price pattern first instead of the macroeconomic environment surrounding BioNexus Gene Lab. By analyzing BioNexus Gene's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of BioNexus Gene's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to BioNexus Gene specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2025 | 2026 (projected) | Payables Turnover | 6.02 | 5.47 | 4.92 | 3.48 | Days Of Inventory On Hand | 49.2 | 61.65 | 70.9 | 98.57 |
BioNexus Gene January 10, 2026 Technical Indicators
Most technical analysis of BioNexus help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for BioNexus from various momentum indicators to cycle indicators. When you analyze BioNexus charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.09) | |||
| Market Risk Adjusted Performance | (0.74) | |||
| Mean Deviation | 2.32 | |||
| Coefficient Of Variation | (781.68) | |||
| Standard Deviation | 3.0 | |||
| Variance | 8.98 | |||
| Information Ratio | (0.16) | |||
| Jensen Alpha | (0.44) | |||
| Total Risk Alpha | (0.73) | |||
| Treynor Ratio | (0.75) | |||
| Maximum Drawdown | 14.92 | |||
| Value At Risk | (5.43) | |||
| Potential Upside | 4.23 | |||
| Skewness | (0.34) | |||
| Kurtosis | 0.2069 |
BioNexus Gene January 10, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as BioNexus stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 70.44 | ||
| Daily Balance Of Power | 0.67 | ||
| Rate Of Daily Change | 1.01 | ||
| Day Median Price | 3.97 | ||
| Day Typical Price | 3.96 | ||
| Price Action Indicator | (0.01) |
Complementary Tools for BioNexus Stock analysis
When running BioNexus Gene's price analysis, check to measure BioNexus Gene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioNexus Gene is operating at the current time. Most of BioNexus Gene's value examination focuses on studying past and present price action to predict the probability of BioNexus Gene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioNexus Gene's price. Additionally, you may evaluate how the addition of BioNexus Gene to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |